Amgen, the world's largest biotech company, sees its shares prices dropped more than 30% from its highs and becomes out of favor from Wall Street in recent months. It is time for value Gurus to step in. During the first quarter we have seen 4 Gurus bought into Amgen. Who says value investors don't like growth?
AMGN's Business and Market Valuation
Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It is the word's largest biotechnology company by sales. Amgen Inc. has a market cap of $66.34 billion, it was traded at around $57.61 with P/E ratio of 22.05 and P/S ratio of 4.53. Today Amgen Inc. said it would buy privately held Alantos Pharmaceuticals, which has a promising diabetes medicine in development, for $300 million. Gurus' Positions with AMGN
Amgen Inc. is owned by 8 Gurus. All of them have favorable positions over Amgen. 4 Gurus Initiated Positions in AMGN:
Contrarian investor David Dreman bought 3,252,231 shares in the quarter ended 03/31/2007, which is 0.93% of the $19.6 billion portfolio of Dreman Value Management. It is also the largest purchase of David Dreman. Richard Pzena bought 4,390,390 shares in the quarter ended 03/31/2007, which is 0.92% of the $26.73 billion portfolio of Pzena Investment Management LLC. Brian Rogers bought 3,000,000 shares in the quarter ended 03/31/2007, which is 0.69% of the $24.17 billion portfolio of T Rowe Price Equity Income Fund. Bill Miller bought 200,000 shares in the quarter ended 03/31/2007, which is 0.06% of the $20.03 billion portfolio of Legg Mason Value Trust. 2 Gurus Increased Positions in AMGN:
Mark Hillman owns 29,970 shares as of 03/31/2007, an increase of 8.16% of from the previous quarter. This position accounts for 0.23% of the $731 million portfolio of Hillman Capital Management. Ruane Cunniff owns 9,670 shares as of 03/31/2007, an increase of 0.52% of from the previous quarter. This position accounts for less than 0.01% of the $12.47 billion portfolio of Ruane & Cunniff & Goldfarb Inc. 2 Gurus Kept Positions in AMGN Unchanged:
Edward Owens owns 9,989,355 shares as of 03/31/2007, which accounts for 2.28% of the $24.52 billion portfolio of Vanguard Health Care Fund. Chris Davis owns 5,500 shares as of 03/31/2007, which accounts for less than 0.01% of the $91.56 billion portfolio of Davis Selected Advisers. Insiders' Positions with AMGN
Recent Trades of Amgen Inc. Directors and Officers:
Executive V.P., Operations Dennis M Fenton sold 15,143 shares of AMGN stock on 06/04/2007 at the average price of $56.72, the price of the stock has increased by 1.57% since.
AMGN's Business and Market Valuation
Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It is the word's largest biotechnology company by sales. Amgen Inc. has a market cap of $66.34 billion, it was traded at around $57.61 with P/E ratio of 22.05 and P/S ratio of 4.53. Today Amgen Inc. said it would buy privately held Alantos Pharmaceuticals, which has a promising diabetes medicine in development, for $300 million. Gurus' Positions with AMGN
Amgen Inc. is owned by 8 Gurus. All of them have favorable positions over Amgen. 4 Gurus Initiated Positions in AMGN:
Contrarian investor David Dreman bought 3,252,231 shares in the quarter ended 03/31/2007, which is 0.93% of the $19.6 billion portfolio of Dreman Value Management. It is also the largest purchase of David Dreman. Richard Pzena bought 4,390,390 shares in the quarter ended 03/31/2007, which is 0.92% of the $26.73 billion portfolio of Pzena Investment Management LLC. Brian Rogers bought 3,000,000 shares in the quarter ended 03/31/2007, which is 0.69% of the $24.17 billion portfolio of T Rowe Price Equity Income Fund. Bill Miller bought 200,000 shares in the quarter ended 03/31/2007, which is 0.06% of the $20.03 billion portfolio of Legg Mason Value Trust. 2 Gurus Increased Positions in AMGN:
Mark Hillman owns 29,970 shares as of 03/31/2007, an increase of 8.16% of from the previous quarter. This position accounts for 0.23% of the $731 million portfolio of Hillman Capital Management. Ruane Cunniff owns 9,670 shares as of 03/31/2007, an increase of 0.52% of from the previous quarter. This position accounts for less than 0.01% of the $12.47 billion portfolio of Ruane & Cunniff & Goldfarb Inc. 2 Gurus Kept Positions in AMGN Unchanged:
Edward Owens owns 9,989,355 shares as of 03/31/2007, which accounts for 2.28% of the $24.52 billion portfolio of Vanguard Health Care Fund. Chris Davis owns 5,500 shares as of 03/31/2007, which accounts for less than 0.01% of the $91.56 billion portfolio of Davis Selected Advisers. Insiders' Positions with AMGN
Recent Trades of Amgen Inc. Directors and Officers:
Executive V.P., Operations Dennis M Fenton sold 15,143 shares of AMGN stock on 06/04/2007 at the average price of $56.72, the price of the stock has increased by 1.57% since.
